Dr. Avneet Kaur, MD

Dr. Kaur practices at Redlands Community Hospital in Redlands, California, part of Redlands Community Hospital.

Dr. Kaur's NPI, 1568955680, was assigned on June 13, 2018. Dr. Kaur graduated from Ross University School of Medicine in 2017. Dr. Kaur's California license number on file is A173528.

Dr. Kaur's primary practice is Redlands Community Hospital, at 350 Terracina Blvd, Redlands, CA 92373 in San Bernardino County. The practice phone is (909) 335-5500.

Dr. Kaur's primary practice is Redlands Community Hospital in Redlands, California, part of Redlands Community Hospital. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Kaur to 4 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Kaur is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Kaur's licenses on file in 2 states: California and Maryland.

Dmand AI lists atrial fibrillation and flutter, chronic diabetes, chronic hypertension, chronic nasal allergies, chronic obstructive pulmonary disease (COPD), high cholesterol, tobacco use and underactive thyroid among the conditions Dr. Kaur treats.

CMS data shows 102 Medicare services from Dr. Kaur across 2 procedure codes in 2024, all of them office visits, for 57 Medicare patients. Medicare paid $7,361 for them. Every service was in an office.

CMS counts 57 Medicare patients who saw Dr. Kaur in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 62, with 72% women.

In 2024, Dr. Kaur wrote 2,716 Medicare Part D claims for 350 patients. 87% of them were for generic drugs. CMS names the drug for 2,067 of them, across 68 drugs with 11 or more claims each, at $108,329 in total drug cost. In 2023, CMS named 724 claims across 31 drugs.

Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaur as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 58 papers to Dr. Kaur, published from 2012 to 2024. 2024 was the busiest year, with 12. The most frequent topics are Anti-Inflammatory Agents, Structure-Activity Relationship and Cyclooxygenase 2 Inhibitors. Dr. Kaur has published most often in Cureus. Dr. Kaur's most frequent co-authors are Jonathan P. Palma, MD, Yao Sun, MD and Pankaj Garg, MD.

CMS Open Payments shows 30 general payments to Dr. Kaur from 12 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Corcept Therapeutics paid the most, $189.

Dr. Kaur graduated from Ross University School of Medicine in 2017.

Dr. Kaur is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.